Skip to main content
Egyptian Journal of Medical Human Genetics

Table 3 Comparison between AML cases vs. control group regarding pretreatment METTL3 gene expression level at diagnosis

From: Methyltransferase-like 3 gene (METTL3) expression and prognostic impact in acute myeloid leukemia patients

METTL3 gene expression (pretreatment level)

AML group (n = 40)

Control group (n = 20)

z test

p value

Median (IQR)

6.95 (2.5–10.5)

1.18 (0.5–1.9)

18.544

< 0.001**

  1. IQR interquartile range, z Mann–Whitney test, HS highly significant
  2. **p value < 0.001
Back to article page